{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:51:31Z","timestamp":1793317891118,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>As a common complication of Sjogren syndrome (SS), SS-related dry eye disease (SS-DED) significantly affects the patients\u2019 quality of life. Pro-inflammatory cytokines in tears are widely believed to play a crucial role in the pathogenesis of SS-DED. A systematic literature review with meta-analyses was conducted to provide a quantitative summary of tear cytokine levels in SS-DED compared with non-SS-DED and healthy controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The PubMed, Embase, Web of Science, Ovid, and Scopus databases were searched until June 2022. Original case\u2013control studies investigating tear cytokines in SS-DED patients compared with non-SS-DED or healthy individuals were included. Differences of cytokines levels were compared with random-effects standardized mean differences\u2005\u00b1\u200595% confidence intervals calculated as the effect size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 15 articles, 809 subjects (302 for SS-DED, 220 for non-SS-DED, and 287 for healthy controls) were included in the study. SS-DED patients had higher tear levels of interferon-gamma, interleukin (IL)-17, IL-1\u03b2, IL-2, IL-4, IL-6, and IL-8 as compared to healthy controls. As for comparison between SS-DED and non-SS-DED group, the levels of IL-12p70, IL-17, IL-4, IL-6, IL-8, and tumor necrosis factor-alpha were significantly higher in SS-DED patients compared with the non-SS-DED group. The level of epidermal growth factor was significantly lower in SS-DED patients compared with both non-SS-DED patients and healthy controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The findings from this study provide evidence for levels of tear cytokines in SS-DED to become potential diagnostic biomarkers or therapeutic targets. Further studies with a higher number of subjects and improved quality are necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000040669","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T16:03:13Z","timestamp":1733760193000},"page":"e40669","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Tear cytokine levels in Sjogren\u2019s syndrome-related dry eye disease compared with non-Sjogren\u2019s syndrome-related dry eye disease patients: A meta-analysis"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1361-9916","authenticated-orcid":false,"given":"Jiaxi","family":"Li","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihe","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"e3821","DOI":"10.1136\/bmj.e3821","article-title":"Primary Sjogren syndrome.","volume":"344","author":"Ramos-Casals","year":"2012","journal-title":"BMJ"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.survophthal.2019.10.004","article-title":"Primary Sj\u00f6gren's syndrome and the eye.","volume":"65","author":"Bjordal","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sj\u00f6gren's syndrome: a systematic review and meta-analysis.","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome.","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.3390\/ijms222111820","article-title":"Autoimmune epithelitis and chronic inflammation in Sj\u00f6gren's syndrome-related dry eye disease.","volume":"22","author":"Ogawa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1573397112666160714164149","article-title":"Update on Pathogenesis of Sjogren's syndrome.","volume":"13","author":"Sandhya","year":"2017","journal-title":"Curr Rheumatol Rev"},{"issue":"Suppl 126","key":"R7-20250504","first-page":"301","article-title":"Advances, limitations and future perspectives in the diagnosis and management of dry eye in Sj\u00f6gren's syndrome.","volume":"38","author":"Vehof","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.3390\/ijms21093111","article-title":"Dry eye disease and tear cytokine levels-a meta-analysis.","volume":"21","author":"Roda","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","article-title":"Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj\u00f6gren's syndrome keratoconjunctivitis sicca.","volume":"19","author":"Pflugfelder","year":"1999","journal-title":"Curr Eye Res"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.3390\/ijms20215435","article-title":"Invariant NKT cells and rheumatic disease: focus on primary Sjogren syndrome.","volume":"20","author":"Rizzo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1601-0825.2009.01582.x","article-title":"Cytokines in Sj\u00f6gren's syndrome.","volume":"15","author":"Roescher","year":"2009","journal-title":"Oral Dis"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2017.10.019","article-title":"Cytokines as therapeutic targets in primary Sj\u00f6gren syndrome.","volume":"184","author":"Retamozo","year":"2018","journal-title":"Pharmacol Ther"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.autrev.2018.05.005","article-title":"Clinical and immunological parameters of Sj\u00f6gren's syndrome.","volume":"17","author":"Psianou","year":"2018","journal-title":"Autoimmun Rev"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2249.2012.04606.x","article-title":"Selective localization of T helper subsets in labial salivary glands from primary Sj\u00f6gren's syndrome patients.","volume":"169","author":"Maehara","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2249.2002.01869.x","article-title":"The Th1\/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren\u2019s syndrome.","volume":"128","author":"Mitsias","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.iy.12.040194.003223","article-title":"Acquisition of lymphokine-producing phenotype by CD4+ T cells.","volume":"12","author":"Seder","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1615\/CritRevImmunol.v25.i2.10","article-title":"Th1 and Th2 lymphocytes in autoimmune disease.","volume":"25","author":"Crane","year":"2005","journal-title":"Crit Rev Immunol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/intimm\/dxp021","article-title":"Th17 cells: from precursors to players in inflammation and infection.","volume":"21","author":"Awasthi","year":"2009","journal-title":"Int Immunol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3858\/emm.2011.43.1.007","article-title":"Genetic controls of Th17 cell differentiation and plasticity.","volume":"43","author":"Dong","year":"2011","journal-title":"Exp Mol Med"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.4049\/jimmunol.182.3.1247","article-title":"Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression.","volume":"182","author":"Chauhan","year":"2009","journal-title":"J Immunol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ajo.2013.04.003","article-title":"Analysis of tear cytokines and clinical correlations in Sj\u00f6gren syndrome dry eye patients and non-Sj\u00f6gren syndrome dry eye patients.","volume":"156","author":"Lee","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jop.12149","article-title":"Th1 and Th2 polymorphisms in Sj\u00f6gren's syndrome and rheumatoid arthritis.","volume":"43","author":"de Souza","year":"2014","journal-title":"J Oral Pathol Med"},{"key":"R27-20250504","first-page":"513","article-title":"Serum interleukin-17 & nitric oxide levels in patients with primary Sj\u00f6gren's syndrome.","volume":"135","author":"Miletic","year":"2012","journal-title":"Indian J Med Res"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/genes12030365","article-title":"Ophthalmologic manifestations of primary Sj\u00f6gren's syndrome.","volume":"12","author":"Roszkowska","year":"2021","journal-title":"Genes (Basel)"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.1167\/iovs.11-7266","article-title":"Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays.","volume":"52","author":"Boehm","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/art.38007","article-title":"Interleukin-7 enhances the Th1 response to promote the development of Sj\u00f6gren's syndrome-like autoimmune exocrinopathy in mice.","volume":"65","author":"Jin","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13075-015-0582-9","article-title":"Altered balance of interleukin-13\/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sj\u00f6gren's syndrome.","volume":"17","author":"Bian","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mi.2009.5","article-title":"IL-17 disrupts corneal barrier following desiccating stress.","volume":"2","author":"De Paiva","year":"2009","journal-title":"Mucosal Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T21:08:54Z","timestamp":1746306534000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":32,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040669","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]}}}